Eur. J. Med. Chem., 2012, 58, 171-183.

Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors.

Tetrahedron Lett., 2012, 53, 944-947. 

First synthesis of 4-aminopyrido[2',3':4,5]furo[3,2-d]pyrimidines.

Tetrahedron, 2011, 67, 4767-4773.

A convenient route to functionalized 3-amino-N-methylfuro[3,2-b]pyridine-2-carboxamides.

Tetrahedron, 2010, 66, 4490-4494.

A convenient route to functionalized 3-amino-6-bromofuro[3,2-b]pyridine-2-carboxamides.

J. Enz. Inh. Med. Chem. 2008, 23(5), 719-727.

Indole carboxamides inhibit bovine testes hyaluronidase at pH 7.0 and indole acetamides activate the enzyme at pH 3.5 by different mechanisms.

J. Enz. Inh. Med. Chem. 2008, 23(5), 728-738.

N-Pyridinyl(methyl)-indole-1- or 3-propanamides and propenamides acting as topical and systemic anti-inflammatory inhibitors.

Tetrahedron 2004, 60, 6079-6083.

Synthesis of 1-benzyl-8,9-dihydroimidazo[4,5-c]pyrrolo[3,2-g]quinolin-4(5H)-one via palladium-catalyzed intramolecular arylation.

J. Enz. Inh. Med. Chem. 2003, 18, 201-208.

New N-pyridinyl (methyl) N1-substituted-3-indolylpropanamides acting as topical and systemic inflammation inhibitors.

J. Enz. Inh. Med. Chem. 2003, 18, 253-257.

Potential Inhibitors of Angiogenesis. Part II: 3-(Azolylmethylene)-2,3-dihydrobenzo[b]furan-2-ones.

J. Enz. Inh. Med. Chem. 2003, 18, 243-252. 

Potential Inhibitors of Angiogenesis. Part I: 3-(Imidazol-4(5)-yl methylene)indolin-2-ones.

J. Enz. Inh. Med. Chem. 2002, 17, 415-424.

New N-pyridinyl(methyl)indole-2 and 3-(alkyl)carboxamides and derivatives acting as systemic and topical inflammation inhibitors.

Eur. J. Med. Chem. 2001, 36, 545-553.

N-Pyridinyl-indole-3-(alkyl)carboxamides and derivatives as potential systemic and topical inflammation inhibitors.